Cancer systemic active immunotherapy today — prospects for tomorrow Jordan U. Gutterman Editorial Review Pages: 1 - 9
E rosette forming lymphoblasts fail to stimulate allogeneic cells in mixed leukocyte culture (MLC) B. G. LeventhalE. LeungD. G. Poplack Original Papers Pages: 21 - 25
Immunologic responses in patients with pulmonary carcinoma receiving immunotherapy E. MankiewiczV. KurtiR. Papenburg Original Papers Pages: 27 - 39
Ability of renal carcinoma tissue extract to induce leukocyte migration inhibition in patients with nonmetastatic renal carcinoma: Correlation with clinical and histopathological findings M. KjaerN. Christensen Original Papers Pages: 41 - 48
Direct cytotoxicity test applied to patients in stage I and II of malignant skin melanoma E. KristensenR. Reimann Original Papers Pages: 49 - 55
Histologic evaluation of L1210 leukemia in treated and untreated mice Richard T. GlassEdwin C. GlassellG. Mark Kollmorgen Original Papers Pages: 57 - 62
Evaluation of time and dose in treating mammary adenocarcinoma with immunostimulants William A. SansingJerald J. KillionG. Mark Kollmorgen Original Papers Pages: 63 - 68
Cellular immunity in patients with malignant melanoma and their household contacts L. E. SpitlerF. N. LittooyR. W. Sagebiel Original Papers Pages: 69 - 76
Animal models for tumor immunotherapy — A commentary D. S. MartinR. L. StolfiR. A. Fugmann Letter To The Editors Pages: 77 - 79